Skip to content

David Matthew T Insider Trading -- Recent SEC Form 4 Transactions

David Matthew T (CIK 1811612) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-16). Recent activity: Buy ATNM (250,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-10-16Actinium Pharmaceuticals, Inc. (ATNM)Chief Financial OfficerBuy250,000$0

Source: SEC Form 4 filings · as of 2026-10-16